Apollo Hospitals Enterprise trades in fine fettle on BSE

13 Jul 2016 Evaluate

Apollo Hospitals Enterprise is currently trading at Rs 1390.25, up by 12.25 points or 0.89% from its previous closing of Rs. 1378.00 on the BSE.

The scrip opened at Rs. 1385.00 and has touched a high and low of Rs. 1396.25 and Rs. 1377.00 respectively. So far 7588 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1544.00 on 02-Mar-2016 and a 52 week low of Rs. 1196.50 on 24-Aug-2015.

Last one week high and low of the scrip stood at Rs. 1388.50 and Rs. 1334.05 respectively. The current market cap of the company is Rs. 19341.88 crore.

The promoters holding in the company stood at 34.35%, while Institutions and Non-Institutions held 46.38% and 19.52% respectively.

Apollo Hospitals has signed a memorandum of understanding (MOU) with Stanford University for the Stanford South Asian Translational Heart Initiative (SSAATHI) related to South Asians and Chronic Disease. Together, both parties will attempt to delve deeper into the causes associated with cardiovascular risk in diabetic and prediabetic South Asians. The MoU is the first step towards a long-term partnership that will develop and grow over time.

Conceptualized with the overall objective to reduce cardiovascular mortality in South Asians, the study will capture data on prediabetes and insulin resistance, help physicians understand early patterns of glycemic imbalance, help them understand the epigenetic impact on genetically similar populations, and achieve targeted lifestyle and medical therapy. The collaboration will at a later stage look at moving towards a larger Framingham type study that was developed with the objective of identifying common factors or characteristics contributing to chronic vascular diseases in Massachusetts.

Both the organizations are driven by the same objective of strengthening and broadening research on Non-Communicable Diseases (NCD’s), while also promoting the need for healthy living. Apollo’s rich experience in public health service and research expertise associated with guidance from Stanford will help physicians unravel more details on the NCD conundrum and devise necessary preventive interventions to deal with the same.

Apollo Hospitals is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.

Apollo Hospital Ent. Share Price

7235.90 -34.80 (-0.48%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7235.90
Max Healthcare Inst 1036.55
Narayana Hrudayalay 1918.80
Aster DM Healthcare 599.60
Global Health 1144.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×